Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 22, 2007SPIRIT FIRST follow-up analysis shows no stent thrombosis or MACE after one year
Boston Scientific Corporation (NYSE: BSX) today welcomed the results of additional data from the SPIRIT FIRST, II and III...
-
May 22, 2007Study highlights importance of antiplatelet therapy compliance
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of more than 7,000 patients from its ARRIVE...
-
May 22, 2007Trial results report no new stent thrombosis after two years in high-risk patient population
Boston Scientific Corporation (NYSE: BSX) today announced four-year follow-up data from its TAXUS VI clinical trial. The data...
-
May 18, 2007Group supports call for limiting greenhouse gas emissions
Boston Scientific Corporation (NYSE: BSX) today announced that it has joined the U.S. Climate Action Partnership (USCAP). USCAP was formed as a...
-
May 18, 2007Company anticipates broad range of clinical results on endoscopic technologies
Boston Scientific Corporation (NYSE: BSX) today announced that results from several clinical studies designed to determine the safety and efficacy...
-
May 17, 2007Single-operator system allows unprecedented visual access to bile duct
Boston Scientific Corporation (NYSE: BSX) today announced worldwide commercial availability of its SpyGlass™ Direct Visualization System for...
-
May 15, 2007Company to release broad range of clinical data on leading drug-eluting stent portfolio
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the annual Paris...
-
May 14, 2007More than 23,000 patients now enrolled in TAXUS OLYMPIA registry
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the European and Intercontinental phases (II and III)...
-
May 10, 2007New data provide support for minimally invasive treatment of atrial fibrillation (AF)(1)
Boston Scientific Corporation (NYSE: BSX) today commented on data released on May 9th at the American Association for Thoracic Surgery (AATS)...
-
May 9, 2007
Boston Scientific Corporation (NYSE: BSX) today released data reflecting clinical event notification statistics from the first 10,000 patients(1)...